Celldex Therapeutics (CLDX) SEC Filings & 10K Form

$38.21
-1.73 (-4.33%)
(As of 05/17/2024 ET)

Recent Celldex Therapeutics SEC Filings

DateFilerForm TypeView
04/25/2024
7:00 AM
Celldex Therapeutics (Filer)
Form DEF 14A
02/26/2024
7:18 AM
Celldex Therapeutics (Filer)
Form 424B5
02/26/2024
6:05 AM
Celldex Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2024
6:01 AM
Celldex Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
11:52 AM
Celldex Therapeutics (Subject)
Kynam Capital Management, LP (Filed by)
Form SC 13G
02/14/2024
10:48 AM
Celldex Therapeutics (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SC 13G
02/14/2024
6:38 AM
Celldex Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/13/2024
8:41 AM
Celldex Therapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
Form SC 13G
02/09/2024
7:50 AM
Celldex Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
01/04/2024
3:05 PM
Celldex Therapeutics (Issuer)
Martin Samuel Bates (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
3:15 PM
Celldex Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
11/08/2023
4:03 PM
Celldex Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
8:00 AM
Celldex Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
3:05 PM
Celldex Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/20/2023
3:15 PM
Cavanaugh Sarah (Reporting)
Celldex Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:16 PM
Celldex Therapeutics (Issuer)
Crowley Elizabeth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:16 PM
Celldex Therapeutics (Issuer)
Heath-Chiozzi Margo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:17 PM
Celldex Therapeutics (Issuer)
Jimenez Freddy A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:17 PM
Celldex Therapeutics (Issuer)
Martin Samuel Bates (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:18 PM
Celldex Therapeutics (Issuer)
PEPIN RONALD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:19 PM
Celldex Therapeutics (Issuer)
Wright Richard M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:21 PM
Celldex Therapeutics (Issuer)
Young Diane C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:07 PM
Celldex Therapeutics (Issuer)
Shoos Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:07 PM
Celldex Therapeutics (Issuer)
Cohen Cheryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:08 PM
Celldex Therapeutics (Issuer)
CONRAD HERBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:09 PM
Celldex Therapeutics (Issuer)
MARINO JAMES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:10 PM
Celldex Therapeutics (Issuer)
NEIL GARRY ARTHUR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:10 PM
Celldex Therapeutics (Issuer)
PENNER HARRY JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:11 PM
Brownlie Keith L (Reporting)
Celldex Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CLDX) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners